Clinical Trial Update: Metformin Plus Sorafenib for Advanced HCC [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating Metformin plus Sorafenib for advanced hepatocellular carcinoma. The current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Sorafenib (Sorafenib)
• metformin (metformin)

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: UNKNOWN